Literature DB >> 8417635

Increased mortality with gallstone disease: results of a 20-year population-based survey in Pima Indians.

C H Grimaldi1, R G Nelson, D J Pettitt, R E Sampliner, P H Bennett, W C Knowler.   

Abstract

OBJECTIVE: To determine if gallstone disease is associated with an increased risk for malignancy and higher total mortality in Pima Indians.
DESIGN: Inception cohort.
SETTING: American Indian community. PARTICIPANTS: Age- and sex-stratified random population-based sample. MEASUREMENTS: Between 1966 and 1969, an age- and sex-stratified random sample of Pima Indians from the Gila River Indian Community in Arizona was examined to identify evidence of gallstone disease defined as either gallstones (oral cholecystography) or previous cholecystectomy. During 20 years of follow-up, deaths were recorded and underlying causes of death, according to death certificates, were determined.
RESULTS: Among 383 persons with known gallbladder status, 186 (49%) died: 133 among the 222 persons with gallstone disease and 53 among the 161 without. The overall death rate was higher in persons with gallstone disease than in those with normal gallbladders. The age- and sex-adjusted death rate ratio was 1.9 (95% Cl, 1.3 to 2.7). Furthermore, the death rate attributed to malignancies was 6.6 times (Cl, 1.3 to 33.1) as high in persons with gallstone disease as in those with normal gallbladders. Of the 20 fatal malignancies in persons with gallstone disease, 11 occurred in the digestive tract, of which six involved the gallbladder or bile ducts.
CONCLUSIONS: Increased cancer mortality and total mortality were found in Pima Indians with gallstone disease. Although plausible explanations exist for the increased cancer mortality, the increased death rates due to other causes are unexplained. Whether cholecystectomy would change this risk is unknown.

Entities:  

Mesh:

Year:  1993        PMID: 8417635     DOI: 10.7326/0003-4819-118-3-199302010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  15 in total

1.  Gallstone disease is associated with increased mortality in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2010-11-11       Impact factor: 22.682

Review 2.  The treatment of gall stones.

Authors:  N Tait; J M Little
Journal:  BMJ       Date:  1995-07-08

3.  Gallstone characteristics in Mexican Americans and non-Hispanic whites.

Authors:  A K Diehl; W H Schwesinger; D R Holleman; J B Chapman; W E Kurtin
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

Review 4.  Gastroenterology--II: Small and large bowel, pancreas and biliary system.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  1994-09       Impact factor: 2.401

Review 5.  Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

Authors:  Eldon A Shaffer
Journal:  Curr Gastroenterol Rep       Date:  2005-05

6.  Gallstone disease and mortality: a cohort study.

Authors:  Daniel Mønsted Shabanzadeh; Lars Tue Sørensen; Torben Jørgensen
Journal:  Int J Public Health       Date:  2016-11-04       Impact factor: 3.380

7.  Survival until 6 years after cholecystectomy: female population of Denmark, 1977-1983.

Authors:  T F Andersen; H Brønnum-Hansen; T Jørgensen; C Roepstorff; A Loft; M Madsen
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

8.  Gallstone disease and increased risk of mortality: Two large prospective studies in US men and women.

Authors:  Yan Zheng; Min Xu; Yoriko Heianza; Wenjie Ma; Tiange Wang; Dianjianyi Sun; Christine M Albert; Frank B Hu; Kathryn M Rexrode; JoAnn E Manson; Lu Qi
Journal:  J Gastroenterol Hepatol       Date:  2018-05-27       Impact factor: 4.369

Review 9.  Risk Factors for Cholelithiasis.

Authors:  Mila Pak; Glenda Lindseth
Journal:  Gastroenterol Nurs       Date:  2016 Jul-Aug       Impact factor: 0.978

10.  Epidemiology of gallbladder disease: cholelithiasis and cancer.

Authors:  Laura M Stinton; Eldon A Shaffer
Journal:  Gut Liver       Date:  2012-04-17       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.